Related Experiment Videos
Receptor binding properties of amperozide
1Dept. of CNS-Research, Pharmacia LEO Therapeutics AB, Malmö, Sweden.
Pharmacology & Toxicology
|January 1, 1990
Summary
Amperozide shows high affinity for serotonin 5-HT2 receptors and acts as a selective antagonist. This drug also interacts with alpha 1-adrenergic receptors but has low affinity for dopamine D2 receptors.
Area of Science:
- Pharmacology
- Neuroscience
- Biochemistry
Background:
- Receptor pharmacology is crucial for understanding drug mechanisms.
- Serotonin 5-HT2 receptors play a significant role in various physiological processes.
- Amperozide's receptor binding profile requires detailed investigation.
Purpose of the Study:
- To investigate the receptor pharmacology of amperozide.
- To determine amperozide's affinity for various neurotransmitter receptors.
- To elucidate the antagonistic properties of amperozide at the 5-HT2 receptor.
Main Methods:
- In vitro radioligand binding assays were employed.
- Competition binding curves were analyzed using pseudo-Hill coefficients.
- Serotonin-induced inositol-1-phosphate formation in human blood platelets was measured to assess antagonism.
Main Results:
- Amperozide exhibited high affinity for 5-HT2 receptors (Ki = 16.5 nM) and moderate affinity for alpha 1-adrenergic receptors (Ki = 172 nM).
- Low affinity was observed for dopamine D2 receptors (Ki > 400 nM).
- Amperozide demonstrated potent antagonism of 5-HT2 receptor-mediated responses, comparable to ketanserin.
Conclusions:
- Amperozide is a selective 5-HT2 receptor antagonist.
- The drug's affinity for receptors is not significantly influenced by their location.
- These findings provide insights into the pharmacological profile of amperozide for potential therapeutic applications.